Inhibition of uricase by substituted pyrimidines. 1977

F A Sedor, and E G Sander

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014503 Urate Oxidase An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3. Uricase,Oxidase, Urate

Related Publications

F A Sedor, and E G Sander
August 1987, Journal of medicinal chemistry,
F A Sedor, and E G Sander
March 1972, Biochemical pharmacology,
F A Sedor, and E G Sander
October 1953, The Journal of biological chemistry,
F A Sedor, and E G Sander
June 1980, The Biochemical journal,
F A Sedor, and E G Sander
April 1960, Biochimica et biophysica acta,
F A Sedor, and E G Sander
November 1962, Journal of medicinal and pharmaceutical chemistry,
F A Sedor, and E G Sander
August 1985, Clinical biochemistry,
F A Sedor, and E G Sander
September 1963, Journal of medicinal chemistry,
F A Sedor, and E G Sander
February 1982, Talanta,
F A Sedor, and E G Sander
April 2013, The Journal of organic chemistry,
Copied contents to your clipboard!